Molecular Endocrinology of Cancer: Volume 1, Part 2, Endocrine Therapies
Series: Cancer: Clinical Science in Practice;
- Publisher's listprice GBP 201.00
-
101 726 Ft (96 882 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 20 345 Ft off)
- Discounted price 81 381 Ft (77 506 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
101 726 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number and title Endocrine Therapies v.1
- Publisher Cambridge University Press
- Date of Publication 26 January 1996
- ISBN 9780521460675
- Binding Hardback
- No. of pages442 pages
- Size 235x156x26 mm
- Weight 715 g
- Language English 0
Categories
Short description:
This 1996 volume from the series Cancer: Clinical Science in Practice considers the many aspects of hormonally dependent cancer.
MoreLong description:
One third of human cancers have a hormonal basis. Breast cancer, the most common cancer of women, is increasing in incidence in many countries, as, in epidemic proportions, is prostate cancer, the second most common cancer of men. Concurrently, the development of molecular biology has led to a refinement of the definition of hormones to include the complex interaction between tumour cells and both locally and distantly secreted factors. This 1996 volume from the series Cancer: Clinical Science in Practice considers the many aspects of hormonally dependent cancer, including the molecular basis for the autocrine and paracrine regulation of cancer, molecular strategies for cancer detection, preventive strategies in limiting the epidemic of hormonally related cancers, and treatment approaches. The concise volumes in this series are intended for a wide audience of clinicians and researchers with an interest in the application of biomedical science to the understanding and management of cancer.
MoreTable of Contents:
Contributor list; Part I. The Regulation of Cancer: 1. The type 1 growth factor receptor family, their ligands and their role in human cancers T. Rajkumar and W. J. Gullick; 2. The fibroblast growth factor family and their receptors Pita Enriquez Harris and John K. Heath; 3. The biological role of transforming growth factor beta in cancer development Bradley A. Arrick and Rik Derynck; 4. Bombesin and its receptor Michael J. Seckl and Enrique Rozengurt; 5. Gonadotrophin-releasing hormone and its receptor Karin A. Eidne and Lorraine Anderson; 6. Cytokines T. Hamblin; Part II. The Prevention of Endocrine-Dependent Tumours: 7. Familial Cancer Audrey D. Goddard and Donald M. Black; 8. Diet Peter Boyle and Patrick Maisonneuve; 9. Breast cancer: new biological approaches to treatment Robert B. Dickson and Robert Clarke; 10. The biological basis for the treatment of prostate cancer Jonathan Waxman, Andrew Stubbs and Hardev Pandha; 11. Carcinoid tumours S. Bloom and P. Hammond; Part III. Endocrine Complications of Cancer Treatment: 12. Humoral hypercalcaemia John J. Wysolmerski and Arthur E. Braodus; 13. Anaemia of cancer Carole B. Miller and Jerry L. Spivak; Index.
More
